Abstract
Hyperbaric oxygen therapy (HBOT) has been used to treat individuals with autism. However, few studies of its effectiveness have been completed. The current study examined the effects of 40 HBOT sessions at 24% oxygen at 1.3 ATA on 11 topographies of directly observed behavior. Five replications of multiple baselines were completed across a total of 16 participants with autism spectrum disorders. No consistent effects were observed across any group or within any individual participant, demonstrating that HBOT was not an effective treatment for the participants in this study. This study represents the first relatively large-scale controlled study evaluating the effects of HBOT at the level of the individual participant, on a wide array of behaviors.
This is a preview of subscription content, access via your institution.






References
Al-Waili, N. S., & Butler, G. J. (2006). Effects of hyperbaric oxygen on inflammatory response to wound and trauma: Possible mechanism of action. The Scientific World Journal, 6, 425–441.
Aman, M. G., & Singh, N. N. (1994). Aberrant behavior checklist–community: Supplementary manual. East Aurora, NY: Slosson Educational Publications.
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th edn, Text Revision). Washington, DC: American Psychiatric Association.
Anderson, D. C., Bottini, A. G., Jaqiella, W. M., Westphal, B., Ford, S., Rockswold, G. L., et al. (1991). A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke, 22, 1137–1142.
Ashwood, P., Anthony, A., Pellicer, A. A., Torrente, F., Walker-Smith, J. A., & Wakefield, A. J. (2003). Intestinal lymphocyte populations in children with regressive autism: Evidence for extensive mucosal immunopathology. Journal of Clinical Immunology, 23, 504–517.
Ashwood, P., Anthony, A., Torrente, F., & Wakefield, A. J. (2004). Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10. Journal of Clinical Immunology, 24, 664–673.
Autism Research Institute (2007). Autism Treatment Evaluation Checklist. Retrieved from http://autism.com/ari/atec/.
Balzola, F., Barbon, V., Repici, A., Rizzetto, M., Clauser, D., Gandione, M., et al. (2005). Panenteric IBD-like disease in a patient with regressive autism shown for the first time by the wireless capsule enteroscopy: Another piece in the jigsaw of this gut-brain syndrome? The American Journal of Gastroenterology, 100(4), 979–981.
Bennett, M., & Heard, R. (2004). Hyperbaric oxygen therapy for multiple sclerosis. Cochrane Database of Systematic Reviews, 1, CD003057.
Bennett, M. H., Trytko, B., & Jonker, B. (2004). Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury. Cochrane Database Systemic Reviews, 4, CD004609.
Buchman, A. L., Fife, C., Torres, C., Smith, L., & Aristizibal, J. (2001). Hyperbaric oxygen therapy for severe ulcerative colitis. Journal of Clinical Gastroenterology, 33, 337–339.
Cohen, I. L., & Sudhalter, V. (2005). The PDD behavior inventory. Lutz, FL: Psychological Assessment Resources, Inc.
Collet, J. P., Vanasse, M., Marois, P., Amar, M., Goldberg, J., Lambert, J., et al. (2001). Hyperbaric oxygen for children with cerebral palsy: A randomised multicentre trial. HBO-CP Research Group. Lancet, 357(9256), 582–586.
Crosland, K. A., Zarcone, J. R., Lindauer, S. E., Valdovinos, M. G., Zarcone, T. J., Hellings, J. A., et al. (2003). Use of functional analysis methodology in the evaluation of medication effects. Journal of Autism and Developmental Disorders, 33, 271–279.
Furlano, R. I., Anthony, A., Day, R., Brown, A., McGarvey, L., Thomson, M. A., et al. (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. The Journal of Pediatrics, 138, 366–372.
Gessell, L. B. (2008). Hyperbaric oxygen therapy indications. Durham, NC: Undersea and Hyperbaric Medical Society.
Gorgulu, S., Yagci, G., Kaymakcioglu, N., Ozkara, M., Kurt, B., Ozcan, A., et al. (2006). Hyperbaric oxygen enhances the efficiency of 5-aminosalicylic acid in acetic acid-induced colitis in rats. Digestive Diseases and Sciences, 51, 480–487.
Granpeesheh, D., Tarbox, J., Dixon, D., Wilke, A. E., Allen, S., & Bradstreet, J. J. (2010). Randomized trial of hyperbaric oxygen therapy for children with autism. Research in Autism Spectrum Disorders, 4, 265–268.
Green, V. A., Pituch, K. A., Itchon, J., Choi, A., O’Reilly, M., & Sigafoos, J. (2006). Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27, 70–84.
Gulec, B., Yasar, M., Yildiz, S., Oter, S., Akay, C., Deveci, S., et al. (2004). Effect of hyperbaric oxygen on experimental acute distal colitis. Physiological Research, 53, 493–499.
Gurbuz, A. K., Elbuken, E., Yazgan, Y., & Yildiz, S. (2003a). A different therapeutic approach in patients with severe ulcerative colitis: Hyperbaric oxygen treatment. Southern Medical Journal, 96(6), 632–633.
Gurbuz, A. K., Elbuken, E., Yazgan, Y., & Yildiz, S. (2003b). A different therapeutic approach in severe ulcerative hyperbaric oxygen treatment. Romanian Journal of Gastroenterology, 12(2), 170–171.
Guy, W. (1976). Clinical global impression. ECDEU Assessment Manual for Psychopharmacology, revised. Rockville, MD: National Institute of Mental Health.
Hardy, P., Collet, J., Goldberg, J., Ducruet, T., Vanasse, M., Lambert, J., et al. (2002). Neuropsychological effects of hyperbaric oxygen therapy in cerebral palsy. Developmental Medicine and Child Neurology, 44(7), 436–446.
Helms, A. K., Whelan, H. T., & Torbey, M. T. (2005). Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovascular Diseases, 20(6), 417–426.
Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. Journal of Pediatrics, 135, 559–563.
Iwata, B. A., Dorsey, M. F., Slifer, K. J., Bauman, K. E., Richman, G. S. (1994). Toward a functional analysis of self-injury. Journal of Applied Behavior Analysis, 27, 197–209. (Reprinted from Analysis and Intervention in Developmental Disabilities, 2, 3–20, 1982).
Jain, K. (2004). Textbook of hyperbaric medicine. Toronto: Hogrefe & Huber Pub.
Kazdin, A. E. (1982). Single-case research designs: Methods for clinical and applied settings. New York, NY: Oxford University Press.
Kleijnen, J., & Knipschild, P. (1995). Hyperbaric oxygen for multiple sclerosis. Review of controlled trials. Acta Neurologica Scandinavica, 91(5), 330–334.
Kogan, M. D., et al. (2009). Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007. Pediatrics, 124, 1395–1403.
Lerman, D. C., Sansbury, T., Hovanetz, A., Wolever, E., Garcia, A., O’Brien, E., et al. (2008). Using behavior analysis to examine the outcomes of unproven therapies: An evaluation of hyperbaric oxygen therapy for children with autism. Behavior Analysis in Practice, 1, 50–58.
Lord, C., Rutter, M., Goode, S., Heemsbergen, J., Jordan, H., Mawhood, L., et al. (1989). Autism diagnostic observation schedule: A standardized observation of communicative and social behavior. Journal of Autism and Developmental Disorders, 19, 185–212.
McDonagh, M., Helfand, M., Carson, S., & Russman, B. S. (2004). Hyperbaric oxygen therapy for traumatic brain injury: A systematic review of the evidence. Archives of Physical Medicine and Rehabilitation, 85, 1198–1204.
McDonagh, M. S., Morgan, D., Carson, S., & Russman, B. S. (2007). Systematic review of hyperbaric oxygen therapy for cerebral palsy: The state of the evidence. Developmental Medicine and Child Neurology, 49(12), 942–947.
Nighoghossian, N., & Trouillas, P. (1995). Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. Stroke, 26(8), 1369–1372.
Nikfarjam, M., Cuthbertson, C. M., Malcontenti-Wilson, C., Muralidharen, V., Milar, I., & Christophi, C. (2007). Hyperbaric oxygen therapy reduces severity and improves survival in severe acute pancreatitis. Journal of Gastrointestinal Surgery, 11, 1008–1015.
Pardo, C. A., Vargas, D. L., & Zimmerman, A. W. (2005). Immunity, neuroglia and neuroinflammation in autism. International Review of Psychiatry, 17, 485–495.
Rockswold, S. B., Rockswold, G. L., & Defillo, A. (2007). Hyperbaric oxygen in traumatic brain injury. Neurological Research, 29, 162–172.
Rossignol, D. A. (2007). Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. Medical Hypotheses, 68, 1208–1227.
Rossignol, D. A., & Rossignol, L. W. (2006). Hyperbaric oxygen therapy may improve symptoms in autistic children. Medical Hypotheses, 67, 216–228.
Rossignol, D. A., Rossignol, L. W., James, S. J., Melnyk, S., & Mumper, E. (2007). The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: An open-label pilot study. BMC Pediatrics, 7, 36.
Rossignol, D. A., Rossignol, L. W., Smith, S., Schneider, C., Logerquist, S., Usman, A., et al. (2009). Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial. BMC Pediatrics, 9: doi: 10.1186/1471-2431-9-21.
Rusyniak, D. E., Kirk, M. A., Kao, L. W., Brizendine, E. J., Welch, J. L., Cordell, W. H., et al. (2003). Hyperbaric oxygen therapy in acute ischemic stroke: Results of the hyperbaric oxygen in acute ischemic stroke trial pilot study. Stroke, 34(2), 571–574.
Ryu, Y. H., Lee, J. D., Yoon, P. H., Kim, D. I., Lee, H. B., & Shin, Y. J. (1999). Perfusion impairments in infantile autism on technetium-99 m ethyl cysteinate dimer brain single-photon emission tomography: Comparison with findings on magnetic resonance imaging. European Journal of Nuclear Medicine, 26(3), 253–259.
Shi, X. Y., Tang, Z. Q., Sun, D., & He, X. J. (2006). Evaluation of hyperbaric oxygen treatment of neuropsychiatric disorders following traumatic brain injury. Chinese Medical Journal (Engl), 119, 1978–1982.
Singhal, A. B. (2007). A review of oxygen therapy in ischemic stroke. Neurological Research, 29(2), 173–183.
Sparrow, S., Cicchetti, D., & Balla, D. (2005). Vineland adaptive behavior scales (2nd ed.). Minneapolis, MN: Pearson Assessment.
Starkstein, S. E., Vazquez, S., Vrancic, D., Nanclares, V., Manes, F., Piven, J., et al. (2000). SPECT findings in mentally retarded autistic individuals. The Journal of Neuropsychiatry and Clinical Neurosciences, 12(3), 370–375.
Torrente, F., Ashwood, P., Day, R., Machado, N., Furlando, R. I., Anthony, A., et al. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry, 7(4) 375–382, 334.
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57, 67–81.
Vlodavsky, E., Palzur, E., & Soustiel, J. F. (2006). Hyperbaric oxygen therapy reduces neuroinflammation and expression of matrix metalloproteinase-9 in the rat model of traumatic brain injury. Neuropathology Applied Neurobiology, 32, 40–50.
Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., Montgomery, S. M., Davies, S., et al. (2000). Enterocolitis in children with developmental disorders. The American Journal of Gastroenterology, 95(9), 2285–2295.
Wechsler, D. (1999). Wechsler abbreviated scale of intelligence (WASI). San Antonio, TX: Harcourt Assessment.
Wechsler, D. (2002). Wechsler primary and preschool scale of intelligence™–Third edition (WPPSI™-III). San Antonio, TX: Harcourt Assessment.
Wilcox, J., Tsuang, M. T., Ledger, E., Algeo, J., & Schnurr, T. (2002). Brain perfusion in autism varies with age. Neuropsychobiology, 46(1), 13–16.
Wilson, H. D., Wilson, J. R., & Fuchs, P. N. (2006). Hyperbaric oxygen treatment decreases inflammation and mechanical hypersensitivity in an animal model of inflammatory pain. Brain Research, 1098, 126–128.
Wilson, H. D., Toepfer, V. E., Senapati, A. K., Wilson, J. R., & Fuchs, P. N. (2007). Hyperbaric oxygen treatment is comparable to acetylsalicylic acid treatment in an animal model of arthritis. The Journal of Pain, 8, 924–930.
Zarcone, J. R., Lindauer, S. E., Morse, P. S., Crosland, K. A., Valdovinos, M. G., McKerchar, T., et al. (2004). Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis. American Journal on Mental Retardation, 109, 310–321.
Zarcone, J. R., Napolitano, D., & Valdovinos, M. (2008). Measurement of problem behaviour during medication evaluations. Journal of Intellectual Disability Research, 52, 1015–1028.
Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., et al. (2005). Cerebrospinal fluid and serum markers of inflammation in autism. Pediatric Neurology, 33(3), 195–201.
Acknowledgments
This project was funded by The Thoughtful House Center for Children, The Center for Autism and Related Disorders, and an anonymous donor.
Conflict of interest
One author (Bryan Jepson) used HBOT in some patients outside of the research trial as part of his clinical practice at the Medical Center at Thoughtful House and derived revenue from those patients. No other conflicts of interest are present.
Author information
Authors and Affiliations
Corresponding author
Additional information
Clinical Trials Government Identifier: NCT00406159.
Andrew Wakefield is no longer affiliated with The Thoughtful House.
Rights and permissions
About this article
Cite this article
Jepson, B., Granpeesheh, D., Tarbox, J. et al. Controlled Evaluation of the Effects of Hyperbaric Oxygen Therapy on the Behavior of 16 Children with Autism Spectrum Disorders. J Autism Dev Disord 41, 575–588 (2011). https://doi.org/10.1007/s10803-010-1075-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-010-1075-y
Keywords
- Hyperbaric oxygen therapy
- Autism
- Behavioral pharmacology